Stewart Robert A 4

What Happened

• Robert A. Stewart, a director of CorMedix Inc. (CRMD), was awarded 30,453 restricted stock units (RSUs) on January 26, 2026. The filing shows an acquisition at $0.00 (i.e., a grant rather than a purchase). Each RSU represents the right to receive one share of CorMedix common stock; the units will vest in full on January 26, 2027, subject to continued service.

Key Details

• Transaction date: 2026-01-26 (reported on Form 4 filed 2026-01-27)
• Transaction type/code: Award/Grant (A)
• Shares/units awarded: 30,453 RSUs; grant price recorded as $0.00
• Vesting: RSUs vest in full on 2027-01-26, contingent on continued service (per footnote)
• Shares owned after transaction: Not specified in the provided filing
• Footnotes/Exhibits: Footnote confirms each RSU converts to one share at vesting; Exhibit 24.1 (Power of Attorney) included
• Timeliness: Filing appears timely (reported the day after the grant)

Context

• RSUs are a form of compensation that convert to actual shares only upon vesting; they do not represent immediately tradable stock. Grants to directors are common for compensation and do not by themselves indicate buying or selling sentiment. When these RSUs vest and are settled, they will increase the outstanding share count (dilution), but no immediate cash changed hands at grant.